cancer vaccine

News

Moderna Innovation and Technology Centre

Moderna jab on trial for cancer-causing syndrome

Patients with Lynch syndrome could have a potential treatment on the horizon, as a Moderna mRNA vaccine starts trials at Oxford University.

News

IO Bio plans cancer vaccine filing despite trial miss

IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless.

Oncology

Redefining the future of melanoma treatment: Scancell's bold...

News

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint inhibitor immunotherapy, significantly boosted anti-tumour activit

Oncology

Partner Content

Personalized Cancer Vaccine Summit

The Personalised Cancer Vaccine Summit will return to Boston this December!

Market Access

Deepening perspectives: How social media is driving our unde...

On the 31st of May, news broke that the NHS was launching its “world-first” cancer vaccine matchmaking programme.

Moderna jab on trial for cancer-causing syndrome

IO Bio plans cancer vaccine filing despite trial miss

Redefining the future of melanoma treatment: Scancell's bold...

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Personalized Cancer Vaccine Summit

Deepening perspectives: How social media is driving our unde...

SonoThera's $125m Series B heads recent biofinancings

Discover a new era of healthcare panel engagement: Grounded ...

cancer vaccine

Editor's Picks